Percepta: So, as the Editor of the Life Science Dashboards™ tell us what you have been working on lately.

SK: Well, we are going through some format changes to the Dashboard, including updating the brand and look and feel for 2013, and we’ve also improved the structure of the content somewhat. We’ve just completed a month-long audit of some of…

However, GE/Amersham and Thermo Fisher Scientific Prevail for Certain Chemiluminescent ELISA Segments.

CARLSBAD, Calif.–(BUSINESS WIRE)–Today Percepta Associates launched its Quantitative Immunoassay Life Science Dashboard™ market research report revealing BD Biosciences, EMD Millipore, Life Technologies, Meso Scale Discovery and R&D Systems as leading suppliers in the immunoassay market which includes: colorimetric, chemiluminescent and fluorescent ELISAs, as well as electrochemiluminescence and bead-based…

If you are looking for ways to communicate with researchers that identify themselves as immunology researchers, some of Percepta’s latest data suggests the popularity of various information sources spans a pretty broad spectrum. Search engines still rank high as a place immunologist look for product information. Also popular are peer recommendations, journal citations and company web sites, with more…

As has been shown again and again, seemingly homogeneous cell populations often consist of more than one cell type, which can confound research results. Single-cell research offers a bottom-up approach to circumventing such unwanted cellular heterogeneity. As a testament to its potential promise, the NIH has committed ~$90 million over 5 years to single cell analysis research. At Percepta,…

In February 2013 we polled our panel of fluorescent imaging reagent users regarding their anticipated laboratory budget. Data reveals that commercial users anticipate a slight increase compared to academic users. As shown in the table, 24.1% of commercial users of fluorescent imaging reagents expect their budget to increase over the next 12 months, vs. 17.6% of academic users (a…

If you thought cell therapy had suffered too many setbacks in recent years and was stuck in neutral – think again. In a recent Percepta poll of 250 randomly selected life science researchers working in biotechnology and pharmaceutical companies more than 20% are involved in projects focused on allogeneic or autologous cell therapy and/or regenerative medicine. Even more surprising…

Market Report from Percepta Associates Chinese Researchers more willing to switch between cell culture suppliers for improved service and support

Carlsbad, Calif. – September 25, 2012 – Today, Percepta Associates announced the launch of its Series One 2012 Chinese Cell Culture Life Science Dashboard™ market research report, providing rapid access to actionable key market indicators for the Chinese cell culture…

Sigma, Thermo Fisher, MediaTech and Lonza Jostle for Second Position Revealing a Changing Competitive Landscape Compared to 2010 Cell Culture Life Science DashboardTM Findings

Carlsbad, Calif. – September 5, 2012 – Today, Percepta Associates announces the launch of its Series Four 2012 Cell Culture Life Science DashboardTM market research report, providing rapid access to actionable key market indicators for the…

Revealed in New Protein Electrophoresis & Western Analysis Life Science DashboardTM from Percepta Associates

Carlsbad, Calif. – February 1, 2012 – Today, Percepta Associates announces the launch of the 2012 Protein Electrophoresis & Western Analysis, Series 1 Life Science DashboardTM market research report. This Dashboard reveals key market indicators, such as market size, market shares, growth rates, customer satisfaction/ propensity…

Nucleic Acid Purification Series 3 Life Science DashboardTM from Percepta Associates shows Qiagen market share declines in small scale plasmid isolation offset by gains in total RNA purification segments

Carlsbad, Calif. – October 17, 2011 – Today Percepta Associates announces the launch of the 2011 Nucleic Acid Purification Series 3 Life Science DashboardTM market research report, providing rapid access to…